Although the ATP1A1 is greatly decreased even lost in RCC tissues, it is accurate to catch its downregulation by the sensitive quantitative proteomics identification, which provides a rapid approach to discover novel cancer biomarkers [40]. This evidence concerns the gene ATP1A1 and cancer.